drugset / Trial / NCT04771689

Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients

NCT04771689

Phase 4 Withdrawn Massachusetts General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized clinical study evaluating the effect of buprenorphine/naloxone (bup/nx) sublingual film on postoperative pain management in opioid-tolerant patients.

Timeline

Start
2022-07-01
Primary completion
2025-12-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Buprenorphine Other / unclassified 4 mg Other
Comparator Naloxone Small molecule 1 mg Other

Indications

No indication recorded.